A student-run resource for reliable reports on the latest law and technology news

Written Description Problems of the Monoclonal Antibody Patents after Centocor v. Abbott 

Written By: Hyeongsu Park - Edited By: Kendra Albert

The market for therapeutic antibodies is projected to reach hundreds of billion dollars within the next several years. In Centocor v. Abbott, the Court of Appeals for the Federal Circuit (“Federal Circuit”) held that a patentee cannot claim an antibody unless the specification describes it, even if he/she fully characterizes the antigen, and the court vacated a $1.67 billion jury verdict, the largest patent infringement award in U.S. history.

Read More...

Posted On Mar - 13 - 2014 Comments Off READ FULL POST
  • RSS
  • Facebook
  • Twitter
  • GooglePlay
how-to-draw-an-android-android-phone_1_000000008746_5

Google Appeals Rulin

Google Appeals Ruling that Use of Java APIs in Android ...

Icon-news

Flash Digest: News i

By Ariane Moss Microsoft Tax Banned in Italy In a case filed ...

api_icon

Google Appeals Rulin

By Katherine Kwong – Edited by Ashish Bakshi Petition for Writ ...

13399-surveillance_news

UN Report Finds Gove

By Olga Slobodyanyuk – Edited by Jesse Goodwin The UN Report from ...

PatentDraftingTools

Functional Claim Ele

By Asher Lowenstein – Edited by Mengyi Wang Robert Bosch, LLC, ...